This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Stefano Miglior, MD; Hermann L. Kain, MD; Teodosio Libondi, MD; R. Gilberto González, MD, PhD; Patrick Barnett, MD; Joel M. Krauss; Hong-Ming Cheng, PhD

Arch Ophthalmol. 1986;104(11):1681-1684.

Abstract
• Proton magnetic resonance imaging (MRI) was employed to obtain information on early vitreal changes preceding ophthalmoscopically visible proliferative vitreoretinopathy. Rabbits were injected close to the posterior pole with a suspension of 250 000 cultured homologous fibroblasts. The MRI was carried out using a 1.4-tesla (T) superconducting imager (at a proton frequency of 61.4 MHz). The images were obtained over a span of six days, prior to any detection of proliferative vitreoretinopathy with ophthalmoscopy. As early as two days after injection, an area of increased spin-spin relaxation time (T₂) corresponding to the vitreal injection site became visible. The MRI observations paralleled in vitro changes in proton relaxation times (T₁ [spin-lattice relaxation time] and T₂) after addition of β-N-acetylglucosaminidase to the vitreous. Our data suggest that hyaluronate disruption due to the activity of fibroblastic enzymes may result in fibroblast dispersion and movement in the vitreous and that MRI can provide early signs of vitreal changes that lead to retinal detachment.

Author Affiliations
From the Howe Laboratory of Ophthalmology, Harvard Medical School, and the Massachusetts Eye and Ear Infirmary, Boston.

Footnotes
Accepted for publication May 22, 1986.

Reprint requests to Howe Laboratory of Ophthalmology, 243 Charles St, Boston, MA 02114 (Dr Cheng).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?